Y-Intercept (HK)’s Altimmune ALT Stock Holding History

Y-Intercept (HK)’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32,695	Closed	-$138K	–	1236
2023 Q1	$138K	Buy	+32,695	New	+$388K	0.02%	1021

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Y-Intercept (HK)'s ALT Position: Q2 2023 in Review

Y-Intercept (HK) sold out of Altimmune (ALT) in Q2 2023, closing a stake of 32,695 shares — an estimated $138K sold.

Y-Intercept (HK) first reported a position in ALT in Q1 2023 and held it in 1 quarter. The position peaked at $138K in Q1 2023. 120 funds tracked by Wall St. Rank hold ALT as of Q2 2023.

Y-Intercept (HK) reported no remaining Altimmune position as of Q2 2023 after selling out during the quarter.
Y-Intercept (HK) sold 32,695 Altimmune shares in Q2 2023, an estimated $138K.
Y-Intercept (HK) first reported a position in Altimmune in Q1 2023 and held it in 1 quarter.
Y-Intercept (HK)'s Altimmune position peaked at $138K in Q1 2023.
120 funds tracked by Wall St. Rank held Altimmune as of Q2 2023.

Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.